Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by DryBoneson Aug 22, 2018 2:22am

139 Views

Post# 28497266

RE:RE:re PBI 4050 info update

Biofinder wrote:

DryBones wrote: Nice find Bio, but what was the source?

https://adisinsight.springer.com/drugs/800030515

A very interesting link there. https://adisinsight.springer.com The number of active clinical trials is over 8000 world wide. But, most are in the USA. No wonder the FDA takes forever.